Castrillón RLE, Palma RA, Macín CS

Idioma: Español
Referencias bibliográficas: 53
Paginas: 231-238
Archivo PDF: 167.53 Kb.

RESUMEN

La lactoferrina (LF) es una proteína presente en secreciones y es un componente de los gránulos específicos del neutrófilo que se libera cuando estas células son activadas por agentes periodontopatógenos en el caso de los procesos inflamatorios de gingivitis y periodontitis. Se ha correlacionado el nivel de LF con el número de neutrófilos presentes en las lesiones y se propone a esta molécula como un marcador bioquímico de actividad periodontal. Debido a la diversidad de actividades biológicas de la LF como su capacidad citotóxica y su interferencia en el desarrollo de biopelículas, entre otras, se propone su uso en la prevención y tratamiento en enfermedades periodontales.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Alderova L, Baroskova A, Faldyna M. Lactoferrin: a review. Veterinari Medicina 2008; 9: 457-468.

2. Brock HJ. The physiology of lactoferrin. Biochem Cell Biol 2002; 80: 1-6.

3. Ferenc LP, Viljoen M. Lactoferrin: A general review. Haematologica 1995; 80: 252-267.

4. Vorland HL. Lactoferrin: A multifunctional glycoprotein. APMIS 1999; 107: 971-981.

5. Drago ME. Actividades antibacterianas de lactoferrina. Enf Inf Microbiol 2006; 26: 58-63.

6. Samaranayake HY, Samaranayake LP, Wu PC, SO M. The antifungal effect of lactoferin and lysozyme on Candida krusei and Candida albicans. APMIS 1997; 105: 875-883.

7. Hegenauer J, Saltman P. Iron and susceptibility to infectious disease. Science 1975; 188: 1038-1039.

8. de Lillo A, Quirós LM, Fierro JF. Relationship between antibacterial activity and cell surface binding of lactoferrin in species of genus Microcuccus. FEMS Microbiol Letters 1997; 150: 89-94.

9. Wakabayashi H, Takase M, Tomita M. Lactoferricin derived from milk protein lactoferrin. Curr Pharm Des 2003; 9: 1277-1287.

10. Dionysius DA, Milne JM. Antibacterial peptides of bovine lactoferrin: Purification and characterization. J Dairy Sci 1997; 80: 667-674.

11. Viejo-Díaz M, Andrés TM, Fierro JF. Effects of human lactoferrin on the cytoplasmic membrane of Candida albicans cells related with its candidacidal activity. FEMS Immunol Med Microbiol 2004; 42: 181-185.

12. Vorland LH, Ulvatne H, Andersen J, Haukland H, Rekdal O, Svendsen JS, Gutteberg TJ. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand J Infect Dis 1998; 30: 513-517.

13. Lupetti A, van Dissel JT, Brouwer CPJM, Nibbering PH. Human antimicrobial peptides’ antifungal activity against Aspergillus fumigatus. Eur J Clin Microbiol Infect Dis 2008; 27: 1125-1129.

14. Castro CE, Koss MA, López ME. Marcadores bioquímicos de la enfermedad periodontal. Med Oral 2003; 8: 322-328.

15. Kalmar RJ, Arnold RR. Killing of Actinobacillus actinomycetemcomitans by human lactoferrin. Infect Immun. 1988; 56: 2552-2557.

16. Aguilera O, Andrés MT, Heath J, Fierro JF, Douglas CWI. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens. FEMS Immunol Med Microbiol 1998; 21: 29-36.

17. Arnold RR, Cole FM, McGhee RJ. A bactericidal effect for human lactoferrin. Science 1977; 197: 263-265.

18. Berlutti F, Ajello M, Bosso P, Morea C, Andrea P, Giobanni A, Piera V. Both lactoferrin and iron influence aggregation and biofilm formation in Streptococcus mutans. BioMetals 2004; 17: 271-278.

19. Shi Y, Kong W, Nakayama K. Human lactoferrin binds and removes the hemoglobin receptor protein of the periodontopathogen Porphyromonas gingivalis. J Biol Chem 2000; 275: 30002-30008.

20. Afugupalli KR, Kalfas S, Edwardsson S, Naidu AS. Lactoferrin interaction with Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol 1995; 10: 35-41.

21. Naidu AS, Arnold RR. Lactoferrin interaction with salmonellae potentiates antibiotic susceptibility. Diag Microbiol Infect Dis 1994; 20: 69-75.

22. Weiss SJ. Tissue destruction by neutrophils. New Engl J Med1 989; 6: 365-376.

23. Gustafsson A, Ito H, Asman B, Bergström K. Hiper-reactive mononuclear cells and neutrophils in chronic periodontitis. J Clin Periodontol 2006; 33: 126-129.

24. Castrillón RLE, Macín CSA, Palma RA. Participación de la interleucina 1b(IL-1b) en periodontitis. Rev Odontol Mex 2007; 11:185-200.

25. Gustafsson A, Asam B. Increased released of free oxygen radicals from peripheral neutrophils in adult periodontitis after Fcg-receptor stimulation. J Clin Periodontol 1996; 23: 38-44.

26. Pi-Fen Wei, Kun-Yen Ho, Yea-Pyng Ho, Yi-Min Wu. Yi-Hsin Yang, Chi-Chen Tsai. The investigation of glutathione peroxidase, lactoferrin, myeloperoxidase and interleukin-1b in gingival crevicular fluid: implications for oxidative stress in human periodontal diseases. J Periodont Res 2004; 39: 287-293.

27. Kishore R, Alugupalli, Kalfas S. Degradation of lactoferrin by periodontitis-associated bacteria. FEMS Microbiol Letters 1996; 145: 209-214.

28. Groenink J, Walgreen-Weterings E, Nazmi K, Bolscher JGM, Veerman ECI, van Winkerlhoff AJ, Amerongen NAV. Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis. J Clin Periodontol 1999; 26: 269-275.

29. Wakabayashi H, Yamauchi K, Kobayashi T, Yaeshima T, Iwatsuki K, Yoshie H. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia. Antimicrob Agents Chemother 2009; 53: 3308-3316.

30. Attström R. Presence of leukocytes in crevicles of healthy and chronically inflamed gingivae. J Periodont Res 1970; 5: 42-47.

31. Figueredo CMS, Gustafsson A. Increased amounts of laminin in GCF from untreated patients with periodontitis. J Clin Perioodontol 2000; 27: 313-318.

32. Asam B, Gustafsson A, Bergström K. Gingival crevicular neutrophils: membrane molecules do not distinguish between periodontitis and gingivitis. J Clin Periodontol 1997; 24: 927-931.

33. Meyle J, Zell S, Brecx M, Heller W. Influence of oral hygiene on elastase concentration of gingival crevicular fluid. J Periodontal Res 1992; 273: 226-231.

34. Figueredo CMS. Aberrant neutrophil reactions in periodontitis.J Periodontol 2005; 76: 951-955.

35. Gustafsson A, Asman B, Bergström K, Söder PO. Granulocyte elastase in gingival crevicular fluid. A possible discriminator between gingivitis and periodontitis. J Clin Periodontol 1992; 19: 535-540.

36. Armitage GC, Jeffcoat MK, Chadwick DE. Longitudinal evaluation of elastase as a marker for the progression of periodontitis. J Periodontol 1994; 652: 120-128.

37. Lamster JB, Oshrain RL, Harper DS, Celenti RS, Hovliaras CA, Gordon JM. Enzyme activity in crevicular fluid for detection and prediction of clinical attachment loss in patient with chronic adult periodontitis 6-month results. J Periodontol 1988; 59: 516-523.

38. Figueredo CMS, Gustafsson A. Protease activity in gingival crevicular fluid. Presence of free protease. J Clin Periodonotol 1998; 25: 306-310.

39. Adonogianaki E, Moughai NA, Kinane DF. Lactoferrin in the gingival crevicle as a marker of polymorphonuclear leucocytes in periodontal diseases. J Clin Periodontol 1993; 20; 26-31.

40. Tsai CC, Kao CC, Chen CC. Gingival crevicular fluid lactoferrin levels in adult periodontitis patients. Aust Dent J 1998; 43: 40-44.

41. Fransson C, Mooney J, Kinane DF, Berglundh T. Differences in the inflammatory response in young and old human subjects during the course of experimental gingivitis. J Clin Periodontol 1999; 26: 453-460.

42. Murray MC, Mooney J, Kinane DF. The relationship between elastase and lactoferin in healthy, gingivitis and periodontitis sites. Oral Dis 1995; 1: 106-109.

43. Ozdemir B, Ozcan G, Karaduman B, Teoman IA, Ayhan E, Ozer N, Us D. Lactoferrin in gingival crevicular fluid and peripheral blood during experimental gingivitis. Eur J Dent 2009; 3: 16-23.

44. Tenovuo J, Lumikari M, Soukka T. Salivary lysozyme, lactoferrin and peroxidase: antibacterial effects on cariogenic bacteria and clinical applications in preventive dentristy. Proc Finn Dent Soc 1991; 87: 197-208.

45. Jentsch H, Sievert Y, Göcke R. Lactoferrin and other markers from gingival crevicular fluid and saliva before and after periodontal treatment. J Clin Periodontol 2004; 31: 511-514.

46. Madianos PN, Bobetsis YA, Kinane DF. Generation of inflammatory stimuli: how bacteria set up inflammatory responses in the gingival. J Clin Periodontol 2005; 32(Suppl 6): 57-71.

47. Betancourt BM, Botero JE, Rivera BS. Biopelículas: una comunidad microscópica en desarrollo. Colomb Med 2004; 35(Supl 1): 34-39.

48. Loesche WJ. The antimicrobial treatment of periodontal disease: changing the treatment paradigm. Crit Rev Oral Biol Med 1999; 10: 245-275.

49. Arslan SY, Leung KP, Wu CD. The effect of lactoferrin on oral bacterial attachment. Oral Microbial Immunol 2009; 24: 411-416.

50. 50.- Singh KP, Parsek RM, Greenberg EP, Welsh JM. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417: 552-555.

51. Singh KP. Iron sequestration by human lactoferrin stimulates P. aeruginosa surface motility and blocks biofilm formation. BioMetals 2004; 17: 267-270.

52. Ammons MC, Ward LS, Fisher ST, Wolcott RD, James GA. In vitro susceptibility of established biofilms composed of a clinical wound isolate of Pseudomonas aeruginosa treated with lactoferrin and xylitol. Int J Antimicrob Agents 2009; 33: 230-236.

53. Naidu AS, Nimmagudda R. Activated lactoferrin. Part 1: a novel antimicrobial formulation. AgroFood industry hi-tech 2003; 14: 7-10.